NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Allscripts Healthcare Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $9.00 -0.10 (-1.10 %) (As of 01/29/2020 03:56 PM ET) Add Compare Today's Range$8.96Now: $9.00▼$9.1650-Day Range$8.91MA: $9.60▼$9.9652-Week Range$8.74Now: $9.00▼$12.40Volume55,574 shsAverage Volume2.16 million shsMarket Capitalization$1.46 billionP/E Ratio7.69Dividend YieldN/ABeta1.38 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:MDRX Previous Symbol CUSIP01988P10 CIK1124804 Webhttp://www.allscripts.com/ Phone800-334-8534Debt Debt-to-Equity Ratio0.51 Current Ratio0.66 Quick Ratio0.66Price-To-Earnings Trailing P/E Ratio7.69 Forward P/E Ratio18.37 P/E Growth1.63 Sales & Book Value Annual Sales$1.75 billion Price / Sales0.84 Cash Flow$1.74 per share Price / Cash Flow5.17 Book Value$9.05 per share Price / Book0.99Profitability EPS (Most Recent Fiscal Year)$0.55 Net Income$412.33 million Net Margins12.00% Return on Equity5.98% Return on Assets2.61%Miscellaneous Employees9,500 Outstanding Shares162,370,000Market Cap$1.46 billion Next Earnings Date2/20/2020 (Estimated) OptionableOptionable Receive MDRX News and Ratings via Email Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:MDRX Rates by TradingView Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions What is Allscripts Healthcare Solutions' stock symbol? Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX." How will Allscripts Healthcare Solutions' stock buyback program work? Allscripts Healthcare Solutions declared that its Board of Directors has approved a share repurchase plan on Thursday, August 2nd 2018, which permits the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 11.3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued. How were Allscripts Healthcare Solutions' earnings last quarter? Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings results on Monday, November, 4th. The software maker reported $0.17 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.17. The software maker earned $445 million during the quarter, compared to the consensus estimate of $450.04 million. Allscripts Healthcare Solutions had a return on equity of 5.98% and a net margin of 12.00%. The business's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.18 earnings per share. View Allscripts Healthcare Solutions' Earnings History. When is Allscripts Healthcare Solutions' next earnings date? Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Allscripts Healthcare Solutions. What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings? Allscripts Healthcare Solutions issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $450-455 million, compared to the consensus revenue estimate of $463.08 million. What price target have analysts set for MDRX? 7 equities research analysts have issued 12-month price targets for Allscripts Healthcare Solutions' stock. Their forecasts range from $10.00 to $13.00. On average, they expect Allscripts Healthcare Solutions' stock price to reach $11.71 in the next year. This suggests a possible upside of 30.2% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions. What is the consensus analysts' recommendation for Allscripts Healthcare Solutions? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions. What are Wall Street analysts saying about Allscripts Healthcare Solutions stock? Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock: 1. According to Zacks Investment Research, "Allscripts ended the third quarter on a mixed note. The company continues to gain from the core Client Services unit, which displayed an improved performance in the quarter. Significant growth in third-quarter bookings also buoys optimism. The company continues to maintain momentum in its Provider business on the back of key client wins across solution set. The company is confident about its near and long-term outlook as it anticipates to benefit from a number of differentiated growth opportunities in both Provider and Veradigm businesses. However, the company witnessed a contraction in both gross and operating margins in the third quarter. It is also exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (12/3/2019) 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019) Has Allscripts Healthcare Solutions been receiving favorable news coverage? News headlines about MDRX stock have trended very positive recently, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of 3.3 on InfoTrie's scale. They also gave news headlines about the software maker a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Allscripts Healthcare Solutions. Who are some of Allscripts Healthcare Solutions' key competitors? Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), HealthStream (HSTM), Vocera Communications (VCRA) and Computer Programs & Systems (CPSI). What other stocks do shareholders of Allscripts Healthcare Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Walgreens Boots Alliance (WBA), Starbucks (SBUX), Activision Blizzard (ATVI), Nuance Communications (NUAN), AK Steel (AKS), Ford Motor (F), Oasis Petroleum (OAS) and American Airlines Group (AAL). Who are Allscripts Healthcare Solutions' key executives? Allscripts Healthcare Solutions' management team includes the folowing people: Mr. Paul M. Black, CEO & Director (Age 61)Mr. Richard J. Poulton, Pres (Age 54)Mr. Dennis M. Olis, Chief Financial Officer (Age 56)Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52) Who are Allscripts Healthcare Solutions' major shareholders? Allscripts Healthcare Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.84%), Smith Graham & Co. Investment Advisors LP (0.59%), California Public Employees Retirement System (0.31%), Retirement Systems of Alabama (0.13%), Arizona State Retirement System (0.06%) and Virginia Retirement Systems ET AL (0.05%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions. Which major investors are selling Allscripts Healthcare Solutions stock? MDRX stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Arizona State Retirement System, Janney Montgomery Scott LLC, Retirement Systems of Alabama and State of Alaska Department of Revenue. View Insider Buying and Selling for Allscripts Healthcare Solutions. Which major investors are buying Allscripts Healthcare Solutions stock? MDRX stock was bought by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, California Public Employees Retirement System, Virginia Retirement Systems ET AL, Campbell & CO Investment Adviser LLC, Eqis Capital Management Inc., First Quadrant L P CA, Carroll Financial Associates Inc. and Dupont Capital Management Corp. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions. How do I buy shares of Allscripts Healthcare Solutions? Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Allscripts Healthcare Solutions' stock price today? One share of MDRX stock can currently be purchased for approximately $9.00. How big of a company is Allscripts Healthcare Solutions? Allscripts Healthcare Solutions has a market capitalization of $1.46 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.View Additional Information About Allscripts Healthcare Solutions. What is Allscripts Healthcare Solutions' official website? The official website for Allscripts Healthcare Solutions is http://www.allscripts.com/. How can I contact Allscripts Healthcare Solutions? Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected] MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 598 (Vote Outperform)Underperform Votes: 642 (Vote Underperform)Total Votes: 1,240MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/29/2020 by MarketBeat.com StaffFeatured Article: Stocks at 52 Week High
